IMAX 📈 Imax - Overview
Exchange: NYSE • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA45245E1097
IMAX: Camera Systems, Film Technology, Entertainment Services, Theater Equipment
IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies. It also offers preventative and emergency maintenance services and quality monitoring to the IMAX network; film post-production services; and IMAX film and digital cameras to content creators. In addition, the company engages in the distribution of large-format documentary films to institutional theaters, as well as live performances and interactive events with artists and creators; after-market sales of IMAX System parts and 3D glasses; sale or lease of IMAX theater systems; provision of management services to three other theaters, as well as production advice and technical assistance to documentary and Hollywood filmmakers; and rental of company's proprietary 2D and 3D large-format film cameras. The company markets its theater systems through a direct sales force and marketing staff to science and natural history museums, zoos, aquaria, and other educational and cultural centers, as well as theme parks, private home theaters, tourist destination sites, fairs, and expositions. It offers its services under the IMAX, IMAX 3D, Experience It In IMAX, The IMAX Experience, DMR, Filmed For IMAXTM, IMAX Live, IMAX Enhanced, and SSIMWAVE. The company operates a network of IMAX systems comprising commercial multiplexes, commercial destinations, and institutional locations in 90 countries and territories. IMAX Corporation was founded in 1967 and is headquartered in Mississauga, Canada. Web URL: https://www.imax.com
Additional Sources for IMAX Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IMAX Stock Overview
Market Cap in USD | 1,346m |
Sector | Communication Services |
Industry | Entertainment |
GiC Sub-Industry | Movies & Entertainment |
IPO / Inception | 1994-06-09 |
IMAX Stock Ratings
Growth 5y | 28.5% |
Fundamental | 2.10% |
Dividend | - |
Rel. Strength Industry | 72.6 |
Analysts | 4.36/5 |
Fair Price Momentum | 25.21 USD |
Fair Price DCF | 17.27 USD |
IMAX Dividends
No Dividends PaidIMAX Growth Ratios
Growth Correlation 3m | 89.5% |
Growth Correlation 12m | 91.9% |
Growth Correlation 5y | 30% |
CAGR 5y | 3.08% |
CAGR/Mean DD 5y | 0.11 |
Sharpe Ratio 12m | 1.46 |
Alpha | 41.07 |
Beta | 0.86 |
Volatility | 32.94% |
Current Volume | 572.2k |
Average Volume 20d | 579.3k |
What is the price of IMAX stocks?
As of December 22, 2024, the stock is trading at USD 24.52 with a total of 572,212 shares traded.
Over the past week, the price has changed by -5.80%, over one month by -1.01%, over three months by +21.87% and over the past year by +64.56%.
As of December 22, 2024, the stock is trading at USD 24.52 with a total of 572,212 shares traded.
Over the past week, the price has changed by -5.80%, over one month by -1.01%, over three months by +21.87% and over the past year by +64.56%.
Is Imax a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Imax is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 2.10 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IMAX as of December 2024 is 25.21. This means that IMAX is currently overvalued and has a potential downside of 2.81%.
Neither. Based on ValueRay Fundamental Analyses, Imax is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 2.10 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IMAX as of December 2024 is 25.21. This means that IMAX is currently overvalued and has a potential downside of 2.81%.
Is IMAX a buy, sell or hold?
Imax has received a consensus analysts rating of 4.36. Therefor, it is recommend to buy IMAX.
Imax has received a consensus analysts rating of 4.36. Therefor, it is recommend to buy IMAX.
- Strong Buy: 7
- Buy: 2
- Hold: 1
- Sell: 1
- Strong Sell: 0
What are the forecast for IMAX stock price target?
According to ValueRays Forecast Model, IMAX Imax will be worth about 27.6 in December 2025. The stock is currently trading at 24.52. This means that the stock has a potential upside of +12.6%.
According to ValueRays Forecast Model, IMAX Imax will be worth about 27.6 in December 2025. The stock is currently trading at 24.52. This means that the stock has a potential upside of +12.6%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 27 | 10.1% |
Analysts Target Price | 24.3 | -0.9% |
ValueRay Target Price | 27.6 | 12.6% |